Health
Savannah Chrisley’s Weight Loss Site Flagged by FDA Over ‘Misleading’ Claims, Given 15 Days to Fix
Savannah Chrisley is facing scrutiny from federal regulators over the wording on her prescription weight loss website.
The 28-year-old reality star received a warning letter from the Food and Drug Administration (FDA) in February after officials reviewed her GoodGirlRX website, TMZ reported.
According to the report, the FDA took issue with phrases used to describe Semaglutide and Tirzepatide products, including “FDA-approved meds” and “FDA-approved options,” and “clinically proven GLP-1 results,” calling the language “misleading.”
The letter reportedly stated that the compounded drug products sold on Chrisley’s website are not FDA-approved and that the wording implied the treatments had been “evaluated for safety and effectiveness when they have not.”
Chrisley was given 15 business days to correct the alleged issues, otherwise she could face legal consequences for being in violation of federal law, according to the report.
It appears some changes have already been made. The phrase “clinically proven” has since been updated to read “clinically studied results,” and disclaimers now state that the GLP-1 drugs sold on GoodGirlRX are “not FDA-approved.”
Chrisley addressed the situation directly in a statement: “This was about website wording, not patient safety. There were no fines and no disciplinary action. We’re proud to help women access licensed physicians and we welcome the FDA’s guidance.”
GoodGirlRX offers several weight loss medications, such as Tirzepatide, Semaglutide, Ozempic, Wegovy, Zepbound and Mounjaro.
Chrisley reportedly launched the site in March 2025. The website explains it was built on a “simple belief: women deserve answers, support, and real solutions that help them feel better from the inside out.”
The site also states that Chrisley created it “to transform the way women understand their health and to make preventative care more accessible to every woman, no matter her stage of life.”
